Efficacy and Safety of Proposed Bevacizumab Biosimilar BE1040V in Patients With Metastatic Colorectal Cancer: A Phase III, Randomized, Double-blind, Noninferiority Clinical TrialHamid Rezvani, Sina Salari, Abolghasem Allahyari et al.|Clinical Therapeutics|2020Cited by 15